Dirks, Bryan

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

Adler, L. A., Dirks, B., Deas, P. F., Raychaudhuri, A., Dauphin, M. R., Lasser, R. A., & Weisler, R. H. (2013) · The Journal of Clinical Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 62

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study

Adler, L. A., Dirks, B., Deas, P., Raychaudhuri, A., Dauphin, M., Saylor, K., & Weisler, R. (2013) · BMC Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 45

The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial

Childress, A. C., Arnold, V., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R., & Lopez, F. A. (2014) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 33

Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity

Ginsberg, L., Katic, A., Adeyi, B., Dirks, B., Babcock, T., Lasser, R., Scheckner, B., & Adler, L. A. (2011) · Current Medical Research and Opinion

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 26

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis

Jain, R., Babcock, T., Burtea, T., Dirks, B., Adeyi, B., Scheckner, B., & Lasser, R. (2011) · Child and Adolescent Psychiatry and Mental Health

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 26

Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults

Brown, T. E., Brams, M., Gasior, M., Adeyi, B., Babcock, T., Dirks, B., Scheckner, B., & Wigal, T. (2011) · Current Medical Research and Opinion

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 24

Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study

Turgay, A., Ginsberg, L., Sarkis, E., Jain, R., Adeyi, B., Gao, J., Dirks, B., Babcock, T., Scheckner, B., Richards, C., et al. (2010) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 23

Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate

Weisler, R., Childress, A., Adler, L., Kollins, S., Goodman, D., Hamdani, & Dirks, B. (2013) · Neuropsychiatric Disease and Treatment

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 16

Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study

Weisler, R., Ginsberg, L., Dirks, B., Deas, P., Adeyi, B., & Adler, L. A. (2017) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 15

Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

Babcock, T., Dirks, B., Adeyi, B., & Scheckner, B. (2012) · BMC Pharmacology and Toxicology

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 14

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years

López, F. A., Childress, A., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R. A., Shepski, J., & Arnold, V. (2017) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 11

Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

Katic, A., Ginsberg, L., Jain, R., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Richards, C., Lasser, R., Turgay, A., et al. (2012) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 10

Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder with Emotional Control Impairments

Katic, A., Dirks, B., Babcock, T., Scheckner, B., Adeyi, B., Richards, C., & Findling, R. L. (2013) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 10

Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

Jain, R., Babcock, T., Burtea, T., Dirks, B., Adeyi, B., Scheckner, B., Lasser, R., Renna, J., & Duncan, D. (2013) · Advances in Therapy

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 9